HCV/GBV-B chimeric virus

Details for Australian Patent Application No. 2009273061 (hide)

Owner Advanced Life Science Institute, Inc.

Inventors Maki, Noboru; Mori, Kenichi; Fukai, Hiromi

Agent Davies Collison Cave

Pub. Number AU-A-2009273061

PCT Pub. Number WO2010/008010

Priority 2008-184179 15.07.08 JP

Filing date 15 July 2009

Wipo publication date 21 January 2010

International Classifications

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

A01K 67/027 (2006.01) Rearing or breeding animals, not otherwise provided for - New breeds of vertebrates

C07K 14/18 (2006.01) Peptides having more than 20 amino acids

C07K 19/00 (2006.01) Hybrid peptides

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 7/00 (2006.01) Viruses, e.g. bacteriophages

Event Publications

10 March 2011 PCT application entered the National Phase

  PCT publication WO2010/008010 Priority application(s): WO2010/008010

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009273105-Azole compound

2009273052-Aptamer against IL-17 and use thereof